Codexis Reports First Quarter 2020 Financial Results
May 07, 2020 16:05 ET
|
Codexis, Inc.
R&D revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19 potential impact Conference...
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
May 06, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone...
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
May 05, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz, Ph.D. as...
Codexis to Hold First Quarter 2020 Conference Call on May 7
April 30, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results after...
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
February 27, 2020 16:05 ET
|
Codexis, Inc.
2019 total revenues increased 13% to $68.5 million with product revenue up 15% and R&D revenue up 11% Ten customers contributed more than $1 million each to 2019 revenues Introduces...
Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27
February 20, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2019 fourth quarter and full year financial...
Halal Ingredients Market To Reach USD 66.9 Billion By 2026 | Reports And Data
January 29, 2020 10:00 ET
|
Reports and Data
New York, Jan. 29, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Halal Ingredients market was valued at USD 46.8 Billion in 2019 and expected to reach...
Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
December 23, 2019 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA...